Nicotinic treatment for degenerative neuropsychiatric disorders such as Alzheimer's disease and Parkinson's disease. (Q34002775)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942039%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

review article

1 reference

title

Nicotinic treatment for degenerative neuropsychiatric disorders such as Alzheimer's disease and Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942039%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942039%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

P A Newhouse

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942039%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

E D Levin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942039%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

English

0 references

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942039%20AND%20SRC:MED&resulttype=core&format=json

Behavioural Brain Research

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942039%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942039%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942039%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

121-129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942039%20AND%20SRC:MED&resulttype=core&format=json

Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21.

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Effects of post-learning smoking on memory consolidation.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Cholinergic-dependent cognitive deficits in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Cholinergic deficiency and frontal dysfunction in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Nicotine may relieve symptoms of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Characterization of L-[3H]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Effect of transdermal nicotine patches on cigarette smoking: a double blind crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Does noise stress modulate effects of smoking/nicotine? Mood, vigilance, and EEG responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Muscarinic and nicotinic contributions to cognitive function and cortical blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Can smoking increase attention in rapid information processing during noise? Electrocortical, physiological and behavioral effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Structuring the acquisition and retrieval environment to facilitate learning in individuals with dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Smoking and Alzheimer's disease: a review of the epidemiological evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

A low dose of subcutaneous nicotine improves information processing in non-smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Nicotinic systems and cognitive function

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Transdermal nicotine effects on attention

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Chronic nicotine working and reference memory effects in the 16-arm radial maze: interactions with D1 agonist and antagonist drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Persistence of chronic nicotine-induced cognitive facilitation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Effects of the nicotinic receptor blocker mecamylamine on radial-arm maze performance in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalocortical projection.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Ventral hippocampal ibotenic acid lesions block chronic nicotine-induced spatial working memory improvement in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Chronic nicotine and withdrawal effects on radial-arm maze performance in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Nicotinic and muscarinic interactions and choice accuracy in the radial-arm maze

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Effects of nicotinic dimethylaminoethyl esters on working memory performance of rats in the radial-arm maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Characterization of the cognitive effects of combined muscarinic and nicotinic blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Nicotinic acetylcholine involvement in cognitive function in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Cortical cerebral blood flow governed by the basal forebrain: Age-related Impairments

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Influence of nicotine on simulator flight performance in non-smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Acute nicotinic blockade produces cognitive impairment in normal humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Effects of nicotinic cholinergic agents on cognitive functioning in Alzheimer's and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Intravenous nicotine in Alzheimer's disease: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in nonsmoking healthy volunteers and in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains--in vivo assessment using positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Beta-amyloidosis in normal aging and transmitter signaling in human temporal lobe.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Effects of mecamylamine on spontaneous EEG and performance in smokers and non-smokers.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Central nicotinic receptor agonists ABT-418, ABT-089, and (-)-nicotine reduce distractibility in adult monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Cerebral perfusion as a diagnostic marker of early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Effects of nicotine gum on repeated administration of the Stroop test

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Distinguishing between attentional and amnestic effects in information processing: the separate and combined effects of scopolamine and nicotine on verbal free recall.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Effects of post-trial administration of nicotine on human memory: evaluating the conditions for improving memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Effortful processing is a requirement for nicotine-induced improvements in memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Moving out of the laboratory: does nicotine improve everyday attention?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Nicotine and tetrahydroaminoacradine: Evidence for improved attention in patients with dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Psychomotor performance in smokers following single and repeated doses of nicotine gum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Cigarette smoking and cognitive performance

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Smoking and the occurrence of Alzheimer's disease: cross-sectional and longitudinal data in a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Cholinergic control of cognitive resources

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Basal forebrain neurons in the dementia of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Nicotinic acetylcholine binding sites in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: An autobiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

Presynaptic modulation of transmitter release by nicotinic receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2800%2900207-2

7 January 2021

10.1016/S0166-4328(00)00207-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942039%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference